The PGY1 Pharmacy Residency at Montefiore Medical Center seeks to develop a pharmacist into a more highly trained, competent and confident health-system pharmacy practitioner. The resident is accountable for achieving positive and safe patient outcomes. The resident provides pharmaceutical care, and education of patients and health care professionals as a member of an interdisciplinary health-care team. Our program allows for added emphasis on drug therapy outcomes through research and quality improvement initiatives, professional development, and writing/publishing depending upon the individual resident's plan.
Health-system clinical pharmacy specialists serve as preceptors for residents throughout core learning experiences in practice management, acute care, and ambulatory care pharmacy practice settings. Additionally, residents are actively involved in all aspects of the management of centralized and decentralized pharmacy services.
The program consists of 6 weeks of general orientation, followed by 10 months of learning experiences.
A maximum of five residents are accepted into the program annually.
Minimum entrance requirement is a Doctor of Pharmacy degree from an accredited college of pharmacy and eligibility for New York internship/licensure. College of pharmacy transcript, curriculum vitae, letter of intent, and three letters of recommendation are also required.
Applicants are accepted through the PHORCAS and the ASHP Matching Program only
The PGY-1 Residency Program in Pharmacy is an accredited program of the American Society of Health-System Pharmacists. It was established in 1968 as the first pharmacy residency in New York City, and was later accredited by the American Society of Hospital Pharmacists in 1975.
Montefiore Medical Center's program builds on a Doctor of Pharmacy (PharmD) education and outcomes to contribute to the development of clinical pharmacists. By completion of our program, residents will be able to care for patients with a wide range of medication-related conditions. In addition, they will be well equipped and eligible for board certification, and postgraduate year two (PGY2) pharmacy residency training.
Toshiba Morgan-Joseph, PharmD is the current director of the residency program.